Announcement of the result of tender procedure No. 03/2021 – ARG
OBJECT FOR THE REQUEST: Development of formulation and manufacturing of investigational medicinal product (IMP) in accordance to Good Manufacturing Practice for clinical trials of phase I & II.
After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:
Ardena Holding NV
Kleimoer 4, 9030 Mariakerke, Belgium
Total net price of the order execution: 836 245,00 EUR (3 751 144,20 PLN)
The Commission recommends the Management Board to perform the order in accordance with the offer submitted by this Contractor.